Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voglibose vs Glibenclamide Add-on to Metformin in T2DM
NCT05688332Phase 3Unknown
- Sponsor
- University of Zambia
- Start
- Aug 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of voglibose in type 2 diabetes mellitus (T2DM), sponsored by University of Zambia. Status: unknown.
02
Drugs
voglibose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05688332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05688332.